TC
AMPH icon

TFS Capital’s Amphastar Pharmaceuticals AMPH Stock Holding History

TFS Capital’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-46,859
Closed -$755K – 736
2016
Q2 		$755K Sell
46,859
-30,501
-39% -$430K 0.14% 250
2016
Q1 		$928K Sell
77,360
-183,066
-70% -$2.16M 0.13% 278
2015
Q4 		$3.71M Sell
260,426
-122,604
-32% -$1.62M 0.4% 52
2015
Q3 		$4.48M Buy
383,030
+67,535
+21% +$1.01M 0.43% 35
2015
Q2 		$5.55M Buy
315,495
+6,871
+2% +$107K 0.54% 18
2015
Q1 		$4.62M Buy
308,624
+294,637
+2,107% +$3.94M 0.45% 30
2014
Q4 		$162K Sell
13,987
-5,100
-27% -$55.5K 0.02% 850
2014
Q3 		$222K Buy
+19,087
New +$199K 0.02% 840

Other funds holding AMPH

BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
TA
Teachers Advisors New York $81.7B AUM 13.62% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

TFS Capital's AMPH Position: Q3 2016 in Review

TFS Capital sold out of Amphastar Pharmaceuticals (AMPH) in Q3 2016, closing a stake of 46,859 shares — an estimated $755K sold.

TFS Capital first reported a position in AMPH in Q3 2014 and held it in 8 quarters. The position peaked at $5.55M in Q2 2015. 135 funds tracked by Wall St. Rank hold AMPH as of Q3 2016.

  • TFS Capital reported no remaining Amphastar Pharmaceuticals position as of Q3 2016 after selling out during the quarter.
  • TFS Capital sold 46,859 Amphastar Pharmaceuticals shares in Q3 2016, an estimated $755K.
  • TFS Capital first reported a position in Amphastar Pharmaceuticals in Q3 2014 and held it in 8 quarters.
  • TFS Capital's Amphastar Pharmaceuticals position peaked at $5.55M in Q2 2015.
  • 135 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q3 2016.

Based on TFS Capital's 13F filing for Q3 2016, filed 10 Nov 2016.